Strahlentherapie und Onkologie

, Volume 188, Issue 3, pp 209–215 | Cite as

Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010

  • R. Sauer
  • H. Creeze
  • M. Hulshof
  • R. Issels
  • O. Ott
  • on behalf of the Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology
Editorial

Keywords

Cervical Cancer Soft Tissue Sarcoma Health Technology Assessment Hyperthermia Treatment Urinary Bladder Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Stellungnahme zum Endbericht „Hyperthermie: Ein systematischer Review“ des Ludwig-Boltzmann-Instituts für Health Technology Assessment, Wien, März 2010, durch den Arbeitskreis für Klinische Hyperthermie-Forschung (Atzelsberger Kreis)

References

  1. 1.
    GBA Gemeinsamer Bundesausschuss der Bundesrepublik Deutschland: Zusammenfassender Bericht des Unterausschusses “Ärztliche Behandlung” des Gemeinsamen Bundesausschusses über die Bewertung gemäß § 135 Abs. 1 SGB V der Hyperthermie (u. a. Ganzkörper-Hyperthermie, Regionale Tiefenhyperthermie, Oberflächen-Hyperthermie, Hyperthermie in Kombination mit Radiatio und/oder Chemotherapie) (2005), available at http://www.g-ba.de/downloads/40-268-236/2005-06-15-BUB-Hyperthermie.pdf, accessed 27 January 2012Google Scholar
  2. 2.
    Mathis S, Johnasson T (2010) Hyperthermie. Decision Support Document 36 (2010); Ludwig Boltzmann Institut für Health Technology Assessment (LBI-HTA) ISSN-online: 1992-0496, available at http://eprints.hta.lbg.ac.at, accessed 27 January 2012Google Scholar
  3. 3.
    Vernon CC, Hand JW, Field SB et al (1996) Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 35:731–744PubMedCrossRefGoogle Scholar
  4. 4.
    Jones EL, Oleson JR, Prosnitz LR et al (2005) Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol 23:3079–3085PubMedCrossRefGoogle Scholar
  5. 5.
    Jones EL, Marks LB, Prosnitz LR (2007) Point: hyperthermia with radiation for chest wall recurrences. J Natl Compr Canc Netw 5:339–344PubMedGoogle Scholar
  6. 6.
    Van der Zee J, Rhoon GC van, Wijnmaalen AJ et al (1999) Reirradiatie met hyperthermie bij patiënten met een recidief mammacarcinoom. Ned Tijd Gen 143:80–84Google Scholar
  7. 7.
    NCCN Clinical Practice Guidelines in Oncology. Breast Cancer: Version 2.2011; available at http://www.nccn.com, accessed 27 January 2012Google Scholar
  8. 8.
    Conceptrichtlijn mammacarcinoom 2011. Internet: Integraal Kankercentrum Nederland. http://www.oncoline.nl, accessed 27 January 2012Google Scholar
  9. 9.
    Chen HW, Jun-Jie F, Wei L (1997) A randomized trial of hyper-thermo-radiochemotherapy for uterine cervix cancer. Chin J Clin Oncol 24:249–251Google Scholar
  10. 10.
    Datta NR, Bose AK, Kapoor HK (1987) Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): a controlled clinical study. Ind Med Gaz 121:68–71Google Scholar
  11. 11.
    Harima Y, Nagata K, Harima K et al (2001) A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia 17:97–105PubMedCrossRefGoogle Scholar
  12. 12.
    Sharma S, Patel FD, Sandhu APS et al (1989) A prospective randomised study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol 5:151–159Google Scholar
  13. 13.
    Vasanthan A, Mitsumori M, Park JH et al (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 61:145–153PubMedCrossRefGoogle Scholar
  14. 14.
    Lutgens L, Zee J van der, Pijls-Johannesma M et al (2010) Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. Cochrane Database Syst Rev DOI 10.1002/14651858.CD006377.pub3Google Scholar
  15. 15.
    Zee J van der, Gonzalez GD, Rhoon GC van et al (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 355:1119–1125PubMedCrossRefGoogle Scholar
  16. 16.
    Franckena M, Stalpers LJ, Koper PC et al (2008) Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys 70:1176–1182PubMedCrossRefGoogle Scholar
  17. 17.
    Krause FS, Walter B, Ott OJ et al (2010) 15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res 31:985–990Google Scholar
  18. 18.
    Ott OJ, Rodel C, Weiss C et al (2009) Radiochemotherapy for bladder cancer. Clin Oncol (R Coll Radiol) 21:557–565Google Scholar
  19. 19.
    Rodel C, Grabenbauer GG, Kuhn R et al (2002) Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol 20:3061–3071PubMedCrossRefGoogle Scholar
  20. 20.
    Wittlinger M, Rodel CM, Weiss C et al (2009) Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 93:358–363PubMedCrossRefGoogle Scholar
  21. 21.
    Colombo R, Da Pozzo LF, Salonia A et al (2003) Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol 21:4270–4276PubMedCrossRefGoogle Scholar
  22. 22.
    Issels R, Lindner LH, Verweij J et al (2010) for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and the European Society for Hyperthermic Oncology (ESHO). Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570PubMedCrossRefGoogle Scholar
  23. 23.
    NCCN Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma: Version 2.2011; available at http://www.nccn.com, accessed 27 January 2012Google Scholar
  24. 24.
    Issels RD, Lindner LH, Wust P et al (2007) Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of locally advanced, high grade soft tissue sarcomas (STS) of the extremities, the body wall and the abdomen: a phase III randomised prospective trial (EORTC-ESHO Intergroup trial) [abstract 10009]. J Clin Oncol 25(Suppl 18):547Google Scholar
  25. 25.
    Bruggmoser G, Bauchowitz S, Canters R et al (2011) Quality assurance for clinical studies in regional deep hyperthermia. Strahlenther Onkol 187:605–610PubMedCrossRefGoogle Scholar
  26. 26.
    Zagar TM et al (2010) Hyperthermia combined with radiation therapy for superficial breast cancer and chest wall recurrence: A review of the randomised data. Int J Hyperthermia 26(7):612–617PubMedCrossRefGoogle Scholar
  27. 27.
    Overgaard J, Gonzalez Gonzalez D, Hulshof MC et al (1995) Randomized trial of hyperthermia as an adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 345:540–543PubMedCrossRefGoogle Scholar
  28. 28.
    Huilgol NG, Gupta S, Sridhar CR (2010) Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther 6(4):492–496PubMedCrossRefGoogle Scholar
  29. 29.
    Valdagni R, Amichetti M (1993) Report of longterm follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys 28:163–169CrossRefGoogle Scholar

Copyright information

© Urban & Vogel 2012

Authors and Affiliations

  • R. Sauer
    • 1
  • H. Creeze
    • 2
  • M. Hulshof
    • 2
  • R. Issels
    • 3
  • O. Ott
    • 1
  • on behalf of the Interdisciplinary Working Group for Clinical Hyperthermia (Atzelsberg Circle) of the German Cancer Society and the German Society of Radiooncology
    • 1
  1. 1.Department of RadiooncologyUniversity Erlangen-NurembergErlangenGermany
  2. 2.Department of RadiotherapyAcademic Medical CenterAmsterdamThe Netherlands
  3. 3.Medical Clinic IIIUniversity Hospital Medical Center GrosshadernMunichGermany

Personalised recommendations